These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 26134677

  • 1. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer.
    Lee HW, Kim SJ, Choi IJ, Song J, Chun KH.
    Clin Exp Metastasis; 2015 Aug; 32(6):593-603. PubMed ID: 26134677
    [Abstract] [Full Text] [Related]

  • 2. Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer.
    Kim SJ, Lee HW, Baek JH, Cho YH, Kang HG, Jeong JS, Song J, Park HS, Chun KH.
    Oncogene; 2016 Jan 14; 35(2):251-60. PubMed ID: 25823029
    [Abstract] [Full Text] [Related]

  • 3. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells.
    Barat S, Chen X, Cuong Bui K, Bozko P, Götze J, Christgen M, Krech T, Malek NP, Plentz RR.
    Stem Cells Transl Med; 2017 Mar 14; 6(3):819-829. PubMed ID: 28186678
    [Abstract] [Full Text] [Related]

  • 4. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
    Shepherd C, Banerjee L, Cheung CW, Mansour MR, Jenkinson S, Gale RE, Khwaja A.
    Leukemia; 2013 Mar 14; 27(3):650-60. PubMed ID: 23038273
    [Abstract] [Full Text] [Related]

  • 5. Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.
    Sakakibara-Konishi J, Ikezawa Y, Oizumi S, Kikuchi J, Kikuchi E, Mizugaki H, Kinoshita I, Dosaka-Akita H, Nishimura M.
    Int J Clin Oncol; 2017 Apr 14; 22(2):257-268. PubMed ID: 27816990
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL, Min M, Shen W, Liu Y.
    Tumour Biol; 2016 Nov 14; 37(11):15145-15155. PubMed ID: 27677287
    [Abstract] [Full Text] [Related]

  • 10. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
    Shen Y, Lv D, Wang J, Yin Y, Miao F, Dou F, Zhang J.
    Anticancer Drugs; 2012 Aug 14; 23(7):683-90. PubMed ID: 22569108
    [Abstract] [Full Text] [Related]

  • 11. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
    Floyd DH, Kefas B, Seleverstov O, Mykhaylyk O, Dominguez C, Comeau L, Plank C, Purow B.
    Neuro Oncol; 2012 Oct 14; 14(10):1215-26. PubMed ID: 22962413
    [Abstract] [Full Text] [Related]

  • 12. Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?
    Kamstrup MR, Biskup E, Gniadecki R.
    Br J Dermatol; 2010 Oct 14; 163(4):781-8. PubMed ID: 20560956
    [Abstract] [Full Text] [Related]

  • 13. Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells.
    Portanova P, Notaro A, Pellerito O, Sabella S, Giuliano M, Calvaruso G.
    Int J Oncol; 2013 Jul 14; 43(1):121-30. PubMed ID: 23686163
    [Abstract] [Full Text] [Related]

  • 14. GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.
    Meng X, Matlawska-Wasowska K, Girodon F, Mazel T, Willman CL, Atlas S, Chen IM, Harvey RC, Hunger SP, Ness SA, Winter SS, Wilson BS.
    Leukemia; 2011 Jul 14; 25(7):1135-46. PubMed ID: 21494254
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer.
    Mizugaki H, Sakakibara-Konishi J, Ikezawa Y, Kikuchi J, Kikuchi E, Oizumi S, Dang TP, Nishimura M.
    Br J Cancer; 2012 Jun 05; 106(12):1953-9. PubMed ID: 22596234
    [Abstract] [Full Text] [Related]

  • 17. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
    Xu GY, Tang XJ.
    Biomed Pharmacother; 2017 Aug 05; 92():95-107. PubMed ID: 28531805
    [Abstract] [Full Text] [Related]

  • 18. Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
    Li ZL, Chen C, Yang Y, Wang C, Yang T, Yang X, Liu SC.
    Int J Clin Exp Pathol; 2015 Aug 05; 8(5):4378-87. PubMed ID: 26191129
    [Abstract] [Full Text] [Related]

  • 19. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B, Liu SH, Guo WD, Zhang B, Wang JP, Cao YK, Liu J.
    World J Gastroenterol; 2015 Sep 07; 21(33):9727-35. PubMed ID: 26361419
    [Abstract] [Full Text] [Related]

  • 20. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G, Deng S, Guo W, Yu L, Yang J, Zhou S, Gao T.
    Mol Carcinog; 2019 Jan 07; 58(1):3-18. PubMed ID: 29964327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.